Deisberanda, Fortunata Saesarria
Unknown Affiliation

Published : 3 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 3 Documents
Search

ANALISIS KADAR ASAM LEMAK BEBAS DAN PENETAPAN BILANGAN ASAM MINYAK CINCALOK Deisberanda, Fortunata Saesarria; Nurbaeti, Siti Nani; Kurniawan, Hadi
Jurnal Mahasiswa Farmasi Fakultas Kedokteran UNTAN Vol 4, No 1 (2019): Jurnal Farmasi Kalbar
Publisher : Jurnal Mahasiswa Farmasi Fakultas Kedokteran UNTAN

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Cincalok merupakan udang fermentasi khas Kalimantan Barat yang memiliki banyak kandungan bermanfaat seperti astaxanthin, omega-3, dan omega-6. Cincalok yang diekstraksi menggunakan minyak VCO telah diuji keamanannya dan memiliki nilai LD50>5000 mg/kgBB (praktis tidak toksik) sehingga berpotensi dikembangkan sebagai suplemen. Penelitian ini bertujuan untuk menguji kualitas minyak cincalok melalui penentuan kadar asam lemak bebas dan bilangan asam. Analisis mutu minyak diperlukan agar menjamin hasil produk minyak cincalok berkualitas, berkhasiat, dan tahan lama. Pengujian dilakukan menggunakan metode titrasi alkalimetri secara triplo. Hasil yang diperoleh yaitu kadar asam lemak bebas berturut-turut 1,031%; 0,807%; 1,031% dan bilangan asam berturut-turut 0,002; 0,002; 0,002. Menurut standar yang ditetapkan oleh IFOMA (International Fishmeal and Oil Manufacturers' Association) kandungan asam lemak bebas minyak hewani yang baik yaitu sebesar 1-7%, sehingga minyak cincalok tergolong baik.
REVIEW: INOVASI TEKNOLOGI FARMASI DALAM MENINGKATKAN KEPATUHAN PENGOBATAN PADA PASIEN PEDIATRIK DAN GERIATRIK Deisberanda, Fortunata Saesarria; Rommy, Rommy
Journal Pharmacy Of Tanjungpura Vol 3, No 1 (2025): Oktober
Publisher : Universitas Tanjungpura

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

This article reviews innovations in pharmaceutical technologies aimed at improving medication adherence in pediatric and geriatric patients, with a focus on innovative formulations. The purpose of this review was to assess the effectiveness of novel formulations in enhancing therapeutic outcomes and patient adherence, as well as to identify challenges in their clinical implementation. The findings from various studies indicate that technologies such as 3D printing, orally disintegrating tablets (ODTs), and chewable tablets improve therapeutic results and patient compliance by offering flexibility in dose adjustments and drug delivery. Additionally, formulations tailored to patient preferences, such as gummies and orally disintegrating films, have proven effective in enhancing medication acceptance, especially in pediatric and geriatric populations. While these technologies show great potential, challenges related to regulation and manufacturing barriers, such as quality standardization and production scalability, remain major obstacles. Therefore, further and more comprehensive research is required to ensure the widespread implementation of these technologies in pediatric and geriatric patient care.
Comparison of The Effectiveness of Intermittent and Continuous Pantoprazole Therapy in Peptic Ulcer Disease Bleeding Wirastuti, Ade; Molidia, Sri Rahmat; Salsabela, Salsabela; Anisya, Kharina; Deisberanda, Fortunata Saesarria; Aqsa, Kathina Deswi; Ajwad, Muhammad Nur; Dermawan, Abdurraafi' Maududi; Fakhruddin, Fakhruddin; Rommy, Rommy
Academic Hospital Journal Vol 8, No 1 (2026)
Publisher : Rumah Sakit Akademik Universitas Gadjah Mada

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22146/ahj.v8i1.115539

Abstract

Background:  Peptic ulcer disease with melena is commonly encountered in clinical practice. Pantoprazole is widely used to control bleeding and heal ulcers, but there is still debate regarding the effectiveness of intermittent bolus administration compared to continuous infusion.Objective: To review and evaluate the literature on the comparative effectiveness of pantoprazole administered via intermittent bolus versus continuous infusion.Methods: This study employed a narrative literature review design. Literature searches were conducted in the PubMed, Google Scholar, ProQuest, and Sage Journals databases for publications from 2020 to 2025 using the keywords: “pantoprazole,” “continuous infusion,” “intermittent bolus,” “effectiveness,” “bleeding,” and “peptic ulcer disease”.Result: Four articles met the inclusion criteria. Two studies reported no significant difference between intermittent bolus and continuous infusion administration. One study found that intermittent bolus administration was associated with a shorter length of stay, whereas another recommended continuous infusion for patients at high risk of upper gastrointestinal bleeding. There was heterogeneity in study design and reported outcomes.Conclusion: There is no significant difference between continuous infusion and intermittent bolus administration of pantoprazole; given the limited number and quality of studies, further research is needed.